VELUCT, a long non-coding RNA with an important cellular function despite low abundance

Judit Danis¹, Márta Széll^{1

2}

Affiliations

Editorial

Judit Danis et al. J Thorac Dis. 2017 Oct.

. 2017 Oct;9(10):3638-3640.

doi: 10.21037/jtd.2017.09.66.

Judit Danis¹, Márta Széll^{1

2}

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance.
Seiler J, Breinig M, Caudron-Herger M, Polycarpou-Schwarz M, Boutros M, Diederichs S. Seiler J, et al. Nucleic Acids Res. 2017 May 19;45(9):5458-5469. doi: 10.1093/nar/gkx076. Nucleic Acids Res. 2017. PMID: 28160600 Free PMC article.

1. Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 2015;47:199-208. 10.1038/ng.3192 - DOI - PMC - PubMed
1. Kapusta A, Feschotte C. Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications. Trends Genet 2014;30:439-52. 10.1016/j.tig.2014.08.004 - DOI - PMC - PubMed
1. Cheng TY, Cramb SM, Baade PD, et al. The international epidemiology of lung cancer: Latest trends, disparities, and tumor characteristics. J Thorac Oncol 2016;11:1653-71. 10.1016/j.jtho.2016.05.021 - DOI - PMC - PubMed
1. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-19. 10.4161/rna.20481 - DOI - PMC - PubMed
1. Abba ML, Patil N, Leupold JH, et al. MicroRNAs as novel targets and tools in cancer therapy. Cancer Lett 2017;387:84-94. 10.1016/j.canlet.2016.03.043 - DOI - PubMed